ZA879173B - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
ZA879173B
ZA879173B ZA879173A ZA879173A ZA879173B ZA 879173 B ZA879173 B ZA 879173B ZA 879173 A ZA879173 A ZA 879173A ZA 879173 A ZA879173 A ZA 879173A ZA 879173 B ZA879173 B ZA 879173B
Authority
ZA
South Africa
Prior art keywords
therapeutic agents
pharmaceutically acceptable
acceptable salt
composition
salt
Prior art date
Application number
ZA879173A
Other languages
English (en)
Inventor
Govind Pankhania Mahendra
Christopher Meyer Michael
Original Assignee
The Boots Company Plc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc. filed Critical The Boots Company Plc.
Publication of ZA879173B publication Critical patent/ZA879173B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ZA879173A 1986-12-10 1987-12-07 Therapeutic agents ZA879173B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868629567A GB8629567D0 (en) 1986-12-10 1986-12-10 Therapeutic agents

Publications (1)

Publication Number Publication Date
ZA879173B true ZA879173B (en) 1988-06-03

Family

ID=10608805

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879173A ZA879173B (en) 1986-12-10 1987-12-07 Therapeutic agents

Country Status (10)

Country Link
US (1) US4839176A (xx)
EP (1) EP0274845B1 (xx)
JP (1) JP2523726B2 (xx)
AT (1) ATE56866T1 (xx)
DE (1) DE3765243D1 (xx)
ES (1) ES2035086T3 (xx)
GB (1) GB8629567D0 (xx)
GR (1) GR3001185T3 (xx)
IE (1) IE60702B1 (xx)
ZA (1) ZA879173B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8905815D0 (en) * 1989-03-14 1989-04-26 Beecham Group Plc Medicament
DE3927113C2 (de) * 1989-08-17 1993-11-25 Dolorgiet Gmbh & Co Kg Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
US5217965A (en) * 1991-06-17 1993-06-08 Euroceltique, S.A. Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions
GB9121204D0 (en) * 1991-10-04 1991-11-20 Euro Celtique Sa Medicament
GB2260081B (en) * 1991-10-04 1995-11-29 Euro Celtique Sa Use of ibuprofen/codeine mixtures in treatment of chronic pain
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
AUPM814994A0 (en) * 1994-09-14 1994-10-06 Sterling Winthrop Inc. Codeine-containing formulations
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
US6348216B1 (en) 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
RS49982B (sr) 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US7815936B2 (en) 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
ZA200409537B (en) 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
JP5248733B2 (ja) * 2003-11-28 2013-07-31 エスエス製薬株式会社 揮散防止型固形製剤およびその製造方法
US7358270B2 (en) 2004-01-30 2008-04-15 Astellas Pharma Inc. Treating agent for irritable bowel syndrome
EP2106258B1 (de) 2006-10-20 2012-09-12 Bayer Consumer Care AG Ibuprofen gegen husten
JP2008266270A (ja) * 2007-04-25 2008-11-06 Kowa Co イブプロフェン、トラネキサム酸及び糖アルコールを含有する固形製剤
PT2279731E (pt) * 2008-04-23 2013-08-30 Farmasierra Mfg S L Composição farmacêutica melhorada contendo ibuprofeno e codeína
ES2365961B1 (es) * 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
CA2865917C (en) * 2011-03-01 2020-09-29 4413261 Canada Inc. (Spencer Canada) Two speed monolithic system for controlled release of drugs
JP6075043B2 (ja) * 2012-12-05 2017-02-08 大正製薬株式会社 固形製剤

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792170A (en) * 1972-03-14 1974-02-12 Merck & Co Inc Novel alkylsulfinyl derivatives for pain,fever and inflammation
US3936528A (en) * 1974-02-13 1976-02-03 Syntex Corporation Analgesic formulations having enhanced therapeutic activity
US4029798A (en) * 1975-06-02 1977-06-14 Sumitomo Chemical Company, Limited Analgetic composition
GB1573421A (en) * 1976-05-21 1980-08-20 Ici Ltd Acetic acid derivatives
GB1599518A (en) * 1977-02-21 1981-10-07 Ici Ltd 1,3,5-triazine-2,6-diones and pharmaceutical compositions thereof
GB1599181A (en) * 1977-04-01 1981-09-30 Ici Ltd Oxyalkanoic acid derivatives
US4215117A (en) * 1978-05-26 1980-07-29 The Upjohn Company Stable pharmaceutical formulations
ATE698T1 (de) * 1978-05-26 1982-03-15 Imperial Chemical Industries Plc Analgetische 6-acylaminot etrahydro-1,3,5-triazin-2,4-dion-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
JPS584720A (ja) * 1981-06-26 1983-01-11 ザ・アツプジヨン・カンパニ− 鎮痛用医薬組成物
US4489080A (en) * 1981-06-26 1984-12-18 The Upjohn Company Process for analgesic treatment
US4404210A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and ibuprofen
US4464376A (en) * 1982-07-22 1984-08-07 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
CA1261260A (en) * 1984-04-16 1989-09-26 Anil Salpekar Directly compressible codeine salt compositions
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4587252A (en) * 1984-12-18 1986-05-06 Brighton Pharmaceutical, Inc. Hydrocodone/ibuprofen pharmaceutical compositions and method
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition

Also Published As

Publication number Publication date
US4839176A (en) 1989-06-13
ATE56866T1 (de) 1990-10-15
EP0274845A1 (en) 1988-07-20
JP2523726B2 (ja) 1996-08-14
DE3765243D1 (de) 1990-10-31
EP0274845B1 (en) 1990-09-26
JPS63165320A (ja) 1988-07-08
GB8629567D0 (en) 1987-01-21
IE60702B1 (en) 1994-08-10
IE873238L (en) 1988-06-10
GR3001185T3 (en) 1992-06-30
ES2035086T3 (es) 1993-04-16

Similar Documents

Publication Publication Date Title
GB8629567D0 (en) Therapeutic agents
GB8804164D0 (en) Bandage for administering physiologically active compound
NZ223372A (en) Drug-containing jellifiable pellets
EP0448687A4 (en) Therapeutic decapeptides
EP0310386A3 (en) Therapeutic agents
GB2176999B (en) Sustained release medicament
GB8716975D0 (en) Therapeutic agents
GB8701392D0 (en) Therapeutic agents
GB8616299D0 (en) Administering calcium ascorbate
ZA876845B (en) Pharmacologically active compounds and use
ZA882096B (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2-(bipranole)and its acid addition salts for use as active therapeutic substances
ZA874979B (en) Pharmacologically active compounds and use
ZA888714B (en) Medicament with antiemetic action
CS8802913A2 (en) Hyperthyroidism medicament
EP0174980A4 (en) Use of a manganese compound in the manufacture of a medicament for the treatment of hypothyroidism.
IE870765L (en) Medicament adsorbates
GB8721342D0 (en) Therapeutic agents
GB8730191D0 (en) Pharmacologically active compounds & use
IE870764L (en) Medicament adsorbates with surfactant
GB8709095D0 (en) Administering artificial respiration
GB8712139D0 (en) Administering artificial respiration
IL106709A0 (en) Therapeutic uses of 2',5'-oligoadenylates
GB8703900D0 (en) Therapeutic agent
GB8708234D0 (en) Pharmaceutically active compounds
GB8719717D0 (en) Pharmaceutically active compounds